Previous proteomic profiling of urine samples from five individuals with BLCA and five healthy participants demonstrated substantial elevation of PRDX1 levels among cancer patients (Figure 9A), suggesting its value as a non-invasive diagnostic indicator for initial screening. The gene discussed is PRDX1; the disease is bladder transitional cell carcinoma.